![Nancy Stagliano](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nancy Stagliano
Président chez
ELECTRA THERAPEUTICS, INC.
Profil
Dr. Nancy E.
Stagliano is a Chairman at Electra Therapeutics, Inc., a Chairman & Chief Executive Officer at Neuron23, Inc., an Independent Director at Pandion Operations, Inc. and a Chairman at Star OpCo, Inc. She is on the Board of Directors at Pancreatic Cancer Action Network, Inc. and Pandion Operations, Inc. Dr. Stagliano was previously employed as an Independent Director by biOasis Technologies, Inc., a Chief Executive Officer & Director by True North Therapeutics, Inc., a Chief Executive Officer & Director by iPierian, Inc., a Co-Founder by CytomX Therapeutics, Inc., a Chief Operating Officer by CytomX LLC, a Chief Executive Officer by CytomX Therapeutics Holdings LLC, an Associate Director-Discovery Strategy by Millennium Pharmaceuticals, Inc., and an Independent Director by Pandion Therapeutics, Inc. She received her undergraduate degree from Drexel University, a graduate degree from Drexel University and a doctorate degree from the University of Miami.
Postes actifs de Nancy Stagliano
| Sociétés | Poste | Début |
|---|---|---|
| ELECTRA THERAPEUTICS, INC. | Président | 01/03/2019 |
Pandion Operations, Inc.
 Pandion Operations, Inc. Miscellaneous Commercial ServicesCommercial Services Develops drugs for autoimmune, inflammatory and transplant indications | Directeur/Membre du Conseil | 26/07/2018 |
Neuron23, Inc.
 Neuron23, Inc. Pharmaceuticals: OtherHealth Technology Operates as a biotechnology company that focuses on developing precision medicines for genetically defined neurological and immunological diseases | Directeur Général | 01/10/2020 |
Pancreatic Cancer Action Network, Inc.
 Pancreatic Cancer Action Network, Inc. Medical/Nursing ServicesHealth Services Operates a charity which focuses on the early diagnosis of pancreatic cancer | Directeur/Membre du Conseil | 04/08/2020 |
Star Therapeutics, Inc.
 Star Therapeutics, Inc. BiotechnologyHealth Technology Develops antibody therapies for hematology and immunology problems | Président | 01/06/2018 |
Anciens postes connus de Nancy Stagliano
| Sociétés | Poste | Fin |
|---|---|---|
| PANDION THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/04/2021 |
| BIOASIS TECHNOLOGIES INC. | Directeur/Membre du Conseil | 25/11/2019 |
True North Therapeutics, Inc.
 True North Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies that selectively inhibit the complement system to treat rare diseases | Fondateur | 01/06/2017 |
iPierian, Inc.
 iPierian, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical products | Directeur Général | 01/04/2014 |
| ░░░░░░ ░░░ | ░░░░░░░░░ ░░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Nancy Stagliano
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
54
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Drexel University
 Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Miami
 University of Miami Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
biOasis Technologies, Inc.
 biOasis Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapeutic drug delivery for the treatment of neurological diseases and disorders | Health Technology |
CytomX LLC
 CytomX LLC Medical SpecialtiesHealth Technology Develops protein therapeutics and integrated medical diagnostic devices | Health Technology |
CytomX Therapeutics Holdings LLC
 CytomX Therapeutics Holdings LLC Pharmaceuticals: MajorHealth Technology Engaged in the development of new generation targeted antibody therapeutics | Health Technology |
iPierian, Inc.
iPierian, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Pancreatic Cancer Action Network, Inc.
Pancreatic Cancer Action Network, Inc. Medical/Nursing ServicesHealth Services Operates a charity which focuses on the early diagnosis of pancreatic cancer | Health Services |
True North Therapeutics, Inc.
True North Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies that selectively inhibit the complement system to treat rare diseases | Health Technology |
CytomX Therapeutics, Inc.
 CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | Health Technology |
Pandion Operations, Inc.
Pandion Operations, Inc. Miscellaneous Commercial ServicesCommercial Services Develops drugs for autoimmune, inflammatory and transplant indications | Commercial Services |
Neuron23, Inc.
Neuron23, Inc. Pharmaceuticals: OtherHealth Technology Operates as a biotechnology company that focuses on developing precision medicines for genetically defined neurological and immunological diseases | Health Technology |
Pandion Therapeutics, Inc.
 Pandion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company which develops novel therapeutics for autoimmune diseases | Health Technology |
Electra Therapeutics, Inc.
 Electra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapies for immunological diseases and cancer | Health Technology |
Star Therapeutics, Inc.
Star Therapeutics, Inc. BiotechnologyHealth Technology Develops antibody therapies for hematology and immunology problems | Health Technology |
